Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
BIOMARKER:
Chr rearrangement(11)(q23)
Associations
Heatmap
News
Twitter
Trials
Reset Filters
Veri cancer hierarchy
x
x
x
x
Chr rearrangement(11)(q23)
Chr rearrangement(11)(q23)
Acute Myelogenous Leukemia
AML
cytarabine/daunorubicin liposomal formulation
Resistant: C3 – Early Trials
Chr rearrangement(11)(q23)
Chr rearrangement(11)(q23)
Acute Myelogenous Leukemia
AML
cytarabine
Resistant: C3 – Early Trials
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
